Cervical Cancer-Market Insights, Epidemiology and Market Forecast-2023

Publisher Name :
Date: 01-Nov-2016
No. of pages: 77
This report is available at upto 40% Discount. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Cervical Cancer- Market Insights, Epidemiology and Market Forecast-2023-Global" Report provides an overview of the disease and global market size of the Cervical Cancer for the 7MM (United States, EU5 (France, Germany, Italy, Spain and UK) and Japan. It also includes global historical and forecasted epidemiological data for the diagnosed incident cases of Cervical Cancer from 2013-2023. DelveInsight estimates that the therapeutic market size for Cervical Cancer will increase at a Compound Annual Growth Rate of 1.39% and will reach up to USD 231.93 million globally in 2023. The global market size for prophylaxis treatment of Cervical Cancer is expected to grow at a CAGR of 0.71% and reach up to USD 2210.9 Million by 2023.

Cervical Cancer needs to be focused more and more because it adversely affects younger women. It is the fourth most common cause of death among women. Cervical Cancer occurs due to the uncontrolled growth of healthy cells in cervix and forms cervical lesions. It spreads to other tissues such as vagina and uterus. Cervical Cancer is caused by inheritance of defects or mutation in genes. Cervical cancer is also caused due to the infection by the Human Papilloma Virus (HPV) which can infect cells on the surface of the skin and those lining the genitals, anus, mouth and throat, but not the blood or internal organs such as the heart or lungs.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.

Scope

- Report covers the disease overview including pathophysiology, symptoms, diagnosis, disease management, and current treatment options.

- Marketed information including available prescription drugs, its patent and exclusivity details.

- The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5 and Japan from 2013-2023.

- It also provides Market size of Cervical Cancer for United States, EU5 and Japan from 2013 and forecasted Market size to 2023.

- The report will help in developing business strategies by understanding the trends shaping and driving the global market size of the Cervical Cancer for the 7MM (United States, EU5 (France, Germany, Italy, Spain and UK) and Japan.

- Identifying patient populations in the 7MM (United States, EU5 (France, Germany, Italy, Spain and UK) and Japan Cervical Cancer market to improve product design, pricing, and launch plans.

- To understand the future market competition in the 7MM (United States, EU5 (France, Germany, Italy, Spain and UK) and Japan Cervical Cancer therapeutics market, as well as prophylaxis and Insightful review of the key market drivers and barriers.

Cervical Cancer-Market Insights, Epidemiology and Market Forecast-2023

Table of Contents

Report Introduction
Cervical Cancer Disease Overview
Types of Cervical cancer
Staging of Cervical cancer
Pathophysiology
Etiology
Risk Factors
Diagnosis
Epidemiology and Patient Population of Cervical Cancer
United States
Historical Incident Cases of Cervical Cancer in United States (2013-2015)
Forecasted Incident Cases of Cervical Cancer in United States (2016-2023)
Historical Incident Cases of Cervical Cancer diagnosed by stage in United States (2013-2015)
Forecasted Incident Cases of Cervical Cancer diagnosed by stage in United States (2016-2023)
United Kingdom (UK)
Historical Incident Cases of Cervical Cancer in United Kingdom (UK) (2013-2015)
Forecasted Incident Cases of Cervical Cancer in United Kingdom (UK) (2016-2023)
Germany (GE)
Historical Incident Cases of Cervical Cancer in Germany (2013-2015)
Forecasted Incident Cases of Cervical Cancer in Germany (2016-2023)
Italy (IT)
Historical Incident Cases of Cervical Cancer in Italy (2013-2015)
Forecasted Incident Cases of Cervical Cancer in Italy (2016-2023)
France (FR)
Historical Incident Cases of Cervical Cancer in France (2013-2015)
Forecasted Incident Cases of Cervical Cancer in France (2016-2023)
Spain (SP)
Historical Incident Cases of Cervical Cancer in Spain (2013-2015)
Forecasted Incident Cases of Cervical Cancer in Spain (2016-2023)
Japan (JP)
Historical Incident Cases of Cervical Cancer in Japan (2013-2015)
Forecasted Incident Cases of Cervical Cancer in Japan (2016-2023)
Treatment Landscape
Treatment Algorithm
Treatment by Stages
Cervical Cancer Treatment Regimens
Current Unmet Needs
Cervical Cancer Therapeutic Treatments
Bevacizumab (Avastin)
Advantages & Disadvantages
Product Profile
Efficacy
Safety
Side effects of Drug
Avastin Historical Market Sales 2013-2015
Annual cost of therapy of Avastin
Cervical Cancer Prophylaxis Treatments
Cervarix (Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant)
Advantages & Disadvantages
Product Profile
Efficacy
Safety of Cervarix
Side effects of Drug
Cervarix Historical Market Sales 2012-2015
Cost of therapy of Cervarix
GARDASIL/ GARDASIL 9
Advantages & Disadvantages
Product Profile
Efficacy
Safety
Side effects of Drug
Gardasil Historical Market Sales 2012-2015
Cost of therapy of Gardasil
Pipeline Product (Phase III)
Z-100 (Ancer 20)
Axalimogene filolisbac or AXAL (ADXS11-001)
Gimeracil-Oteracil-Tegafur (S-1, TS-1)
Pipeline Product Analysis
Cervical Cancer Therapeutics Market
Historical Cervical Cancer Therapeutics Market (2013-2015)
Forecasted Cervical Cancer Therapeutics Market (2016-2023)
Global
United States (US)
United Kingdom (UK)
Germany (DE)
Italy (IT)
France (FR)
Spain (SP)
Japan (JP)
Cervical Cancer Prophylaxis Treatment
Historical Cervical Cancer Prophylaxis Treatment (2013-2015)
Forecasted Cervical Cancer Prophylaxis Treatment (2016-2023)
Assumptions and Rationale
Market Drivers
Market Barriers
Appendix
Report Methodology
Consulting Services
Disclaimer
About DelveInsight

List of Tables

Table 1:Historical Incident Cases of Cervical Cancer in United States (2013-2015)
Table 2:Forecasted Incident Cases of Cervical Cancer in United States (2016-2023)
Table 3: Historical Incident Cases of Cervical Cancer diagnosed by Cancer Stage, in United States (2013-2015)
Table 4: Forecasted Incident Cases of Cervical Cancer diagnosed by Cancer Stage, in United States (2016-2023)
Table 5: Historical Incident Cases of Cervical Cancer in United Kingdom (UK) (2013-2015)
Table 6: Forecasted Incident Cases of Cervical Cancer in United Kingdom (UK) (2016-2023)
Table 7: Historical Incident Cases of Cervical Cancer in Germany (2013-2015)
Table 8: Forecasted Incident Cases of Cervical Cancer in Germany (2016-2023)
Table 9:Historical Incident Cases of Cervical Cancer inItaly (2013-2015)
Table 10: Forecasted Incident Cases of Cervical Cancer in Italy (2016-2023)
Table 11: Historical Incident Cases of Cervical Cancer in France (2013-2015)
Table 12: Forecasted Incident Cases of Cervical Cancer in France (2016-2023)
Table 13: Historical Incident Cases of Cervical Cancer in Spain (2013-2015)
Table 14: Forecasted Incident Cases of Cervical Cancer in Spain (2016-2023)
Table 15: Historical Incident Cases of Cervical Cancer in Japan (2013-2015)
Table 16: Forecasted Incident Cases of Cervical Cancer in Japan (2016-2023)
Table 17: Cervical Cancer Therapeutics Market in Global (2013-2023)
Table 18: Historical Cervical Cancer Therapeutics Marketin United States (2013-2015)
Table 19: Forecasted Incident Cases of Cervical Cancer in United States (2016-2023)
Table 20: Historical Cervical Cancer Therapeutics Market in United Kingdom (2013-2015)
Table 21: Forecasted Cervical Cancer Therapeutics Market in United Kingdom (2016-2023)
Table 22: Historical Cervical Cancer Therapeutics Market in Germany (2013-2015)
Table 23: Forecasted Cervical Cancer Therapeutics Market in Germany (2016-2023)
Table 22: Historical Cervical Cancer Therapeutics Market in Italy (2013-2015)
Table 23: Forecasted Cervical Cancer Therapeutics Market in Italy (2016-2023)
Table 24: Historical Cervical Cancer Therapeutics Market in France (2013-2015)
Table 25: Forecasted Cervical Cancer Therapeutics Market in France (2016-2023)
Table 24: Historical Cervical Cancer Therapeutics Market in Japan (2013-2015)
Table 25: Forecasted Cervical Cancer Therapeutics Market in Japan (2016-2023)
Table 26:Historical Global Market of Cervical Cancer Prophylaxis Treatment in USD, Million (2013-2015)
Table 27: Forecasted Global Market of Cervical Cancer Prophylaxis Treatment in USD, Million (2016-2023)

List of Figures

Figure 1: Pathophysiology ofCervical Cancer, 2016
Figure 2:Risk Factors ofCervical Cancer, 2016
Figure 3:Historical Incident Cases of Cervical Cancer in United States (2013-2015)
Figure 4:Forecasted Incident Cases of Cervical Cancer in United States (2016-2023)
Figure 5: Historical Incident Cases of Cervical Cancer in United Kingdom (UK) (2013-2015)
Figure 6: Forecasted Incident Cases of Cervical Cancer in United Kingdom (UK) (2016-2023)
Figure 7: Historical Incident Cases of Cervical Cancer in Germany (2013-2015)
Figure 8: Forecasted Incident Cases of Cervical Cancer in Germany (2016-2023)
Figure9:Historical Incident Cases of Cervical Cancer inItaly (2013-2015)
Figure10: Forecasted Incident Cases of Cervical Cancer in Italy (2016-2023)
Figure11: Historical Incident Cases of Cervical Cancer in France (2013-2015)
Figure12: Forecasted Incident Cases of Cervical Cancer in France (2016-2023)
Figure13: Historical Incident Cases of Cervical Cancer in Spain (2013-2015)
Figure14: Forecasted Incident Cases of Cervical Cancer in Spain (2016-2023)
Figure15: Historical Incident Cases of Cervical Cancer in Japan (2013-2015)
Figure16: Forecasted Incident Cases of Cervical Cancer in Japan (2016-2023)
Figure 11:Treatment Algorithm forCervical Cancer, 2016
Figure 12:Treatmentfor patients with Stage IA1 of Cervical Cancer, 2016
Figure 13:Treatmentfor patients with Stage IA2 of Cervical Cancer, 2016
Figure 14:Treatmentfor patients with Stage IB1 of Cervical Cancer, 2016
Figure 15:Treatmentfor patients with Stage IB2 to Stage IVAof Cervical Cancer, 2016
Figure 16:Treatmentfor patients with Stage IVB of Cervical Cancer, 2016
Figure 18: Global Cervical Cancer Therapeutics Market(2013-2023)
Figure13: Historical Cervical Cancer Therapeutics Market in United States (2013-2015)
Figure 14: Forecasted Cervical Cancer Therapeutics Market in United States (2016-2023)
Figure15: Historical Cervical Cancer Therapeutics Market in United Kingdom (2013-2015)
Figure 16: Forecasted Cervical Cancer Therapeutics Market in United Kingdom (2016-2023)
Figure17: Historical Cervical Cancer Therapeutics Market in Germany (2013-2015)
Figure18: Forecasted Cervical Cancer Therapeutics Market in Germany (2016-2023)
Figure19: Historical Cervical Cancer Therapeutics Market in Italy (2013-2015)
Figure 20: Forecasted Cervical Cancer Therapeutics Market in Italy (2016-2023)
Figure 21: Historical Cervical Cancer Therapeutics Market in France (2013-2015)
Figure22: Forecasted Cervical Cancer Therapeutics Market in France (2016-2023)
Figure 23: Historical Cervical Cancer Therapeutics Market in Spain (2013-2015)
Figure24: Forecasted Cervical Cancer Therapeutics Market in Spain (2016-2023)
Figure 25: Historical Cervical Cancer Therapeutics Market in Japan (2013-2015)
Figure26: Forecasted Cervical Cancer Therapeutics Market in Japan (2016-2023)
Figure 27: Historical Global Market of Cervical Cancer Prophylaxis Treatment in USD, Million (2013-2015)
Figure 28: Forecasted Global Market of Cervical Cancer Prophylaxis Treatment in USD, Million (2016-2023)
  • Global Luxury Apparels Market To Do Well Owing To Numerous International Brands
    The global luxury apparels market is fired by the intensifying number of fashion marques and many designers getting wide-ranging clienteles in the form of cost-effective products. The global luxury apparels market was at US$1, 8842.69 million in 2015 and is forecast to reach US$60,793.7 million by the end of 2024. This segment of luxury goods [...]
  • Global Health and Wellness Market Boosted By Organic Products and Wearables
    Healthcare has constantly been a profitable area where buyers spend belligerently. But now, with increasing disposable earnings amid the city population and ground-breaking approaches and innovative products being developed, the overall health and wellness market is estimated for a healthy prospect. The health and wellness market is presently very dynamic owing to growing alertness amongst [...]
  • Increasing New Outlets And Striking Offers To Drive Global Pizza Market
    The global pizza market is predicted to grow at a steady CAGR of about 3% by 2020. Pizza has been gaining massive acceptance globally in the last few years. Consequently, the global pizza market is anticipated to observer considerable progress in the coming years. The growing number of pizzerias is one of the major elements [...]
  • Healthy Diet Demand In Developed Economies To Boost Nutraceuticals
    As customers scuffle to keep up with the frantic lifestyles, the necessity for healthy nutrition rises owing to dearth of time to spend on laborious exercises.  Customers are shifting their attention to swift and healthy food behaviours. Increase in intake of beverages and functional food has offered makers of nutraceuticals with money-spinning prospects to benefit [...]
  • World Economic Forum Unveils Top 10 Emerging Technologies of 2016
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies of 2016. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or [...]
  • Global Paclitaxel Market by Manufacturers, Regions, Type and Application, Forecast to 2021
    Published: 01-Dec-2016        Price: US 3480 Onwards        Pages: 117
    Paclitaxel is a mitotic inhibitor used in cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it taxol.Paclitaxel is a white crystalline powder, odorless and tasteless. It is insoluble in water and soluble in chloroform, acetone and other organic solvents.Scope of the Report:This report ......
  • United States Malignant Melanoma Drug Market Report 2016
    Published: 29-Nov-2016        Price: US 3800 Onwards        Pages: 102
    Notes: Sales, means the sales volume of Malignant Melanoma Drug Revenue, means the sales value of Malignant Melanoma Drug This report studies sales (consumption) of Malignant Melanoma Drug in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Bristol-Myers Squibb - Enzon Pharmaceuticals - Exelixis - GlaxoSmithKline - Merck - Navidea Biopharmaceuticals......
  • Global Triptorelin Acetate Market by Manufacturers, Regions, Type and Application, Forecast to 2021
    Published: 21-Nov-2016        Price: US 3480 Onwards        Pages: 114
    Triptorelin Acetate is a peptide formulation for injection that was initially developed and continues to be used mainly in the treatment of advanced metastatic prostate cancer. Additional indications developed subsequently include the treatment of uterine fibroids (a benign tumour of muscle tissues in the uterus), endometriosis (proliferation of endometrial tissue, the mucous membrane that lines the uterine wall outside the reproductive tract) prior to surgery or when surgery is not deemed appro......
  • Global Lentinan Market by Manufacturers, Regions, Type and Application, Forecast to 2021
    Published: 10-Nov-2016        Price: US 3480 Onwards        Pages: 106
    Lentinan is a beta-glucan (a type of polysaccharide) from the mushroom lentinus edodes (shiTechnologyake mushroom). Technology has been studied in Japan as a treatment for cancer. Scope of the Report: This report focuses on the Lentinan in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufac......
  • Tasigna -Drug Insights, 2016
    Published: 01-Nov-2016        Price: US 1000 Onwards        Pages: 35
    DelveInsight Drug Report, "Tasigna- Drug Insights, 2016" highlights the Tasigna marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight's report covers the Global Market Assessment of the Tasigna covering the total sales estimation and also provides the Tasigna sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Tasigna, patents information and exclus......
  • Temodar -Drug Insights, 2016
    Published: 01-Nov-2016        Price: US 1000 Onwards        Pages: 35
    DelveInsight Drug Report, "Temodar- Drug Insights, 2016" highlights the Temodar marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight's report covers the Global Market Assessment of the Temodar covering the total sales estimation and also provides the Temodar sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Temodar, patents information and exclus......
  • Treanda -Drug Insights, 2016
    Published: 01-Nov-2016        Price: US 1000 Onwards        Pages: 35
    DelveInsight Drug Report, "Treanda- Drug Insights, 2016" highlights the Treanda marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight's report covers the Global Market Assessment of the Treanda covering the total sales estimation and also provides the Treanda sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Treanda, patents information and exclus......
  • Trelstar -Drug Insights, 2016
    Published: 01-Nov-2016        Price: US 1000 Onwards        Pages: 35
    DelveInsight Drug Report, "Trelstar- Drug Insights, 2016" highlights the Trelstar marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight's report covers the Global Market Assessment of the Trelstar covering the total sales estimation and also provides the Trelstar sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Trelstar, patents information and e......
  • Actinic (Solar) Keratosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
    Published: 01-Nov-2016        Price: US 2000 Onwards        Pages: 100
    DelveInsight's Report, "Actinic (Solar) Keratosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the Actinic (Solar) Keratosis Report is to understand the market and pipeline status of the drugs around the Actinic (Solar) Keratosis to explore the generic development opportunities, licensing opportunities and to ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs